Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.

  • Ekso Bionics Holdings' Income towards Parent Company rose 4775.57% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 580.51%. This contributed to the annual value of -$10.7 million for FY2024, which is 3039.44% up from last year.
  • Ekso Bionics Holdings' Income towards Parent Company amounted to -$1.4 million in Q3 2025, which was up 4775.57% from -$4.0 million recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Income towards Parent Company ranged from a high of -$1.4 million in Q3 2025 and a low of -$4.6 million during Q4 2021
  • Over the past 5 years, Ekso Bionics Holdings' median Income towards Parent Company value was -$3.4 million (recorded in 2021), while the average stood at -$3.4 million.
  • Over the last 5 years, Ekso Bionics Holdings' Income towards Parent Company had its largest YoY gain of 4775.57% in 2025, and its largest YoY loss of 6770.44% in 2025.
  • Ekso Bionics Holdings' Income towards Parent Company (Quarter) stood at -$4.6 million in 2021, then increased by 1.87% to -$4.5 million in 2022, then grew by 21.92% to -$3.5 million in 2023, then skyrocketed by 34.88% to -$2.3 million in 2024, then skyrocketed by 37.96% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$4.0 million for Q2 2025, and -$3.5 million during Q1 2025.